Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 18/20 | 0.66 |
| ▸ | DDB1 | Q16531 | 15/20 | 0.66 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | GSPT1 | P15170 | 3/20 | 0.34 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21070670 | 0.92 | CRBN (0.77) | CRBNDDB1GRIN2B | |
| Hydrochloric Acid SCHEMBL30258170 | 0.91 | CRBN (0.76) | CRBNDDB1GRIN2B | |
| SCHEMBL23832535 | 0.88 | CRBN (0.74) | CRBNDDB1 | |
| Trifluoroacetic Acid SCHEMBL27135984 | 0.88 | CRBN (0.58) | CRBNDDB1GSPT1IKZF2CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL26100281 | 0.88 | CRBN (0.58) | CRBNDDB1GSPT1IKZF2CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL27131327 | 0.88 | CRBN (0.58) | CRBNDDB1GSPT1IKZF2CYP2C19 | |
| SCHEMBL31664226 | 0.88 | CRBN (0.71) | CRBNDDB1 | |
| SCHEMBL21107300 | 0.88 | CRBN (0.71) | CRBNDDB1 | |
| Trifluoroacetic Acid SCHEMBL25340753 | 0.86 | DDB1 (0.57) | CRBNDDB1IKZF2 | |
| SCHEMBL21069306 | 0.86 | CRBN (0.71) | CRBNDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023055952-A1 | NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) DEGRADING COMPOUNDS | C4 THERAPEUTICS, INC. (US) | 2023-04-06 | — | — | WO | disclosed |